We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
COVID‐19 in a human T‐cell lymphotropic virus type‐1 carrier.
- Authors
Enomoto, Takatoshi; Shiroyama, Takayuki; Hirata, Haruhiko; Amiya, Saori; Adachi, Yuichi; Niitsu, Takayuki; Noda, Yoshimi; Hara, Reina; Fukushima, Kiyoharu; Suga, Yasuhiko; Miyake, Kotaro; Koyama, Shohei; Iwahori, Kota; Nagatomo, Izumi; Tokuhira, Natsuko; Uchiyama, Akinori; Takeda, Yoshito; Kumanogoh, Atsushi
- Abstract
This is the first report of COVID‐19 in a human T‐cell lymphotropic virus type‐1 (HTLV‐1) carrier. HTLV‐1 infection can cause immune dysfunction even in asymptomatic carriers. This case highlights the need for guidance on management of COVID‐19‐HTLV‐1 coinfection, specifically on the appropriate use of corticosteroid treatment while considering secondary infection.
- Subjects
HTLV; COVID-19
- Publication
Clinical Case Reports, 2022, Vol 10, Issue 2, p1
- ISSN
2050-0904
- Publication type
Article
- DOI
10.1002/ccr3.5463